Skip to main content
KBS_Icon_questionmark link-ico
Study

Go to…

Dual receptor binding radiopharmaceuticals in cancer: targeting the CXCR4 and ACKR3 chemokine receptors

This opportunity Dual receptor binding radiopharmaceuticals in cancer: targeting the CXCR4 and ACKR3 chemokine receptors has now closed.

Academic year:

2023-24

Study mode:

Postgraduate research

Application closing date:

Contact us for details on when to apply